121 related articles for article (PubMed ID: 11513602)
1. Mechanistic effects of autophosphorylation on receptor tyrosine kinase catalysis: enzymatic characterization of Tie2 and phospho-Tie2.
Murray BW; Padrique ES; Pinko C; McTigue MA
Biochemistry; 2001 Aug; 40(34):10243-53. PubMed ID: 11513602
[TBL] [Abstract][Full Text] [Related]
2. A unique autophosphorylation site on Tie2/Tek mediates Dok-R phosphotyrosine binding domain binding and function.
Jones N; Chen SH; Sturk C; Master Z; Tran J; Kerbel RS; Dumont DJ
Mol Cell Biol; 2003 Apr; 23(8):2658-68. PubMed ID: 12665569
[TBL] [Abstract][Full Text] [Related]
3. Kinetic mechanism and rate-limiting steps of focal adhesion kinase-1.
Schneck JL; Briand J; Chen S; Lehr R; McDevitt P; Zhao B; Smallwood A; Concha N; Oza K; Kirkpatrick R; Yan K; Villa JP; Meek TD; Thrall SH
Biochemistry; 2010 Aug; 49(33):7151-63. PubMed ID: 20597513
[TBL] [Abstract][Full Text] [Related]
4. Characterization of protein kinase C theta activation loop autophosphorylation and the kinase domain catalytic mechanism.
Czerwinski R; Aulabaugh A; Greco RM; Olland S; Malakian K; Wolfrom S; Lin L; Kriz R; Stahl M; Huang Y; Liu L; Chaudhary D
Biochemistry; 2005 Jul; 44(28):9563-73. PubMed ID: 16008341
[TBL] [Abstract][Full Text] [Related]
5. Activation loop phosphorylation modulates Bruton's tyrosine kinase (Btk) kinase domain activity.
Lin L; Czerwinski R; Kelleher K; Siegel MM; Wu P; Kriz R; Aulabaugh A; Stahl M
Biochemistry; 2009 Mar; 48(9):2021-32. PubMed ID: 19206206
[TBL] [Abstract][Full Text] [Related]
6. Catalytic reaction pathway for the mitogen-activated protein kinase ERK2.
Prowse CN; Hagopian JC; Cobb MH; Ahn NG; Lew J
Biochemistry; 2000 May; 39(20):6258-66. PubMed ID: 10821702
[TBL] [Abstract][Full Text] [Related]
7. Mutational, kinetic, and NMR studies of the roles of conserved glutamate residues and of lysine-39 in the mechanism of the MutT pyrophosphohydrolase.
Harris TK; Wu G; Massiah MA; Mildvan AS
Biochemistry; 2000 Feb; 39(7):1655-74. PubMed ID: 10677214
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of the catalytic mechanism of the p21-activated protein kinase PAK2.
Wu H; Zheng Y; Wang ZX
Biochemistry; 2003 Feb; 42(4):1129-39. PubMed ID: 12549935
[TBL] [Abstract][Full Text] [Related]
9. Structure of the Tie2 RTK domain: self-inhibition by the nucleotide binding loop, activation loop, and C-terminal tail.
Shewchuk LM; Hassell AM; Ellis B; Holmes WD; Davis R; Horne EL; Kadwell SH; McKee DD; Moore JT
Structure; 2000 Nov; 8(11):1105-13. PubMed ID: 11080633
[TBL] [Abstract][Full Text] [Related]
10. Intrasteric inhibition of ATP binding is not required to prevent unregulated autophosphorylation or signaling by the insulin receptor.
Frankel M; Ablooglu AJ; Leone JW; Rusinova E; Ross JB; Heinrikson RL; Kohanski RA
Mol Cell Biol; 2001 Jul; 21(13):4197-207. PubMed ID: 11390649
[TBL] [Abstract][Full Text] [Related]
11. Deletion of the carboxyl terminus of Tie2 enhances kinase activity, signaling, and function. Evidence for an autoinhibitory mechanism.
Niu XL; Peters KG; Kontos CD
J Biol Chem; 2002 Aug; 277(35):31768-73. PubMed ID: 12082108
[TBL] [Abstract][Full Text] [Related]
12. Insulin receptor autophosphorylation. II. Determination of autophosphorylation sites by chemical sequence analysis and identification of the juxtamembrane sites.
Kohanski RA
Biochemistry; 1993 Jun; 32(22):5773-80. PubMed ID: 8504096
[TBL] [Abstract][Full Text] [Related]
13. Autophosphorylation of KDR in the kinase domain is required for maximal VEGF-stimulated kinase activity and receptor internalization.
Dougher M; Terman BI
Oncogene; 1999 Feb; 18(8):1619-27. PubMed ID: 10102632
[TBL] [Abstract][Full Text] [Related]
14. Direct identification of a major autophosphorylation site on vascular endothelial growth factor receptor Flt-1 that mediates phosphatidylinositol 3'-kinase binding.
Yu Y; Hulmes JD; Herley MT; Whitney RG; Crabb JW; Sato JD
Biochem J; 2001 Sep; 358(Pt 2):465-72. PubMed ID: 11513746
[TBL] [Abstract][Full Text] [Related]
15. Correlation of the phosphorylation states of pp60c-src with tyrosine kinase activity: the intramolecular pY530-SH2 complex retains significant activity if Y419 is phosphorylated.
Boerner RJ; Kassel DB; Barker SC; Ellis B; DeLacy P; Knight WB
Biochemistry; 1996 Jul; 35(29):9519-25. PubMed ID: 8755732
[TBL] [Abstract][Full Text] [Related]
16. Characterization and kinetic mechanism of catalytic domain of human vascular endothelial growth factor receptor-2 tyrosine kinase (VEGFR2 TK), a key enzyme in angiogenesis.
Parast CV; Mroczkowski B; Pinko C; Misialek S; Khambatta G; Appelt K
Biochemistry; 1998 Nov; 37(47):16788-801. PubMed ID: 9843450
[TBL] [Abstract][Full Text] [Related]
17. Insights into the HER-2 receptor tyrosine kinase mechanism and substrate specificity using a transient kinetic analysis.
Jan AY; Johnson EF; Diamonti AJ; Carraway III KL; Anderson KS
Biochemistry; 2000 Aug; 39(32):9786-803. PubMed ID: 10933796
[TBL] [Abstract][Full Text] [Related]
18. Cis-autophosphorylation of juxtamembrane tyrosines in the insulin receptor kinase domain.
Cann AD; Kohanski RA
Biochemistry; 1997 Jun; 36(25):7681-9. PubMed ID: 9201908
[TBL] [Abstract][Full Text] [Related]
19. Mutations in the activation loop tyrosine of the oncoprotein v-Fps.
Saylor P; Hanna E; Adams JA
Biochemistry; 1998 Dec; 37(51):17875-81. PubMed ID: 9922154
[TBL] [Abstract][Full Text] [Related]
20. Steady-state kinetic characterization of kinase activity and requirements for Mg2+ of interleukin-1 receptor-associated kinase-4.
Hekmat-Nejad M; Cai T; Swinney DC
Biochemistry; 2010 Feb; 49(7):1495-506. PubMed ID: 20104875
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
